Insider · CIK 0001265783

AKER HAZEL M

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001265783

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-07-21	Oncternal Therapeutics, Inc.WarrantsA Award	Legal Counsel	AAward	+21K sh	$2.38	+$50K	20,986
2020-07-21	Oncternal Therapeutics, Inc.P Purchase	Legal Counsel	PPurchase	+42K sh	$2.38	+$100K	46,987
2020-03-17	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	+11.1K sh	—	—	11,080
2020-03-17	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	+11.1K sh	—	—	11,080
2020-03-17	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	−11.1K sh	—	—	11,080
2020-03-17	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	+11.1K sh	—	—	11,080
2019-09-12	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	+150K sh	—	—	150,000
2019-09-12	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	−150K sh	—	—	150,000
2019-09-12	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	+150K sh	—	—	150,000
2019-09-12	Oncternal Therapeutics, Inc.Stock OptionA Award	Legal Counsel	AAward	+150K sh	—	—	150,000
2019-06-07	Oncternal Therapeutics, Inc.A Award	Legal Counsel	AAward	+5,015 sh	—	—	5,015
2019-06-07	Oncternal Therapeutics, Inc.WarrantsA Award	Legal Counsel	AAward	+140 sh	—	—	140
2019-06-07	Oncternal Therapeutics, Inc.A Award	Legal Counsel	AAward	+4,284 sh	—	—	4,284
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−109K sh	$10.49	−$1.15M	0
2014-03-19	CADENCE PHARMACEUTICALS INCrestricted stock unitsD Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−120K sh	$14.00	−$1.68M	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−125K sh	$8.60	−$1.08M	0
2014-03-19	CADENCE PHARMACEUTICALS INCU Disposition from Tender	SVP, GC & Secretary	UDisposition from Tender	−3,745 sh	$14.00	−$52.4K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−150K sh	—	—	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−65K sh	$7.99	−$519K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−70K sh	$5.65	−$396K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−15K sh	$4.78	−$71.7K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−200K sh	$4.78	−$956K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−80K sh	$5.45	−$436K	0
2014-03-19	CADENCE PHARMACEUTICALS INCstock option (right to buy)D Disposition to Issuer	SVP, GC & Secretary	DDisposition to Issuer	−321 sh	$10.49	−$3,367.29	0
2014-02-10	CADENCE PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, GC & Secretary	AAward	+120K sh	—	—	120,000
2013-12-16	CADENCE PHARMACEUTICALS INCS Sale	SVP, GC & Secretary	SSale	−13K sh	$8.76	−$114K	3,745
2013-12-16	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−13K sh	—	—	109,451
2013-12-16	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+13K sh	$3.51	+$45.7K	16,759
2013-11-15	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+52.1K sh	$3.51	+$183K	55,801
2013-11-15	CADENCE PHARMACEUTICALS INCS Sale	SVP, GC & Secretary	SSale	−26K sh	$7.81	−$203K	29,773
2013-11-15	CADENCE PHARMACEUTICALS INCS Sale	SVP, GC & Secretary	SSale	−26K sh	$7.00	−$182K	3,745
2013-11-15	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−19.5K sh	—	—	321
2013-11-15	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−32.5K sh	—	—	122,465
2013-07-22	CADENCE PHARMACEUTICALS INCS Sale	SVP, GC & Secretary	SSale	−6,507 sh	$7.81	−$50.8K	3,745
2013-07-22	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+6,507 sh	$3.51	+$22.8K	10,252
2013-07-22	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−6,507 sh	—	—	19,842
2013-07-15	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+6,508 sh	$3.51	+$22.8K	10,253
2013-07-15	CADENCE PHARMACEUTICALS INCS Sale	SVP, GC & Secretary	SSale	−6,508 sh	$7.34	−$47.8K	3,745
2013-07-15	CADENCE PHARMACEUTICALS INCstock option (right to buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−6,508 sh	—	—	26,349
2013-03-13	CADENCE PHARMACEUTICALS INCStock option (right to buy)A Award	SVP, GC & Secretary	AAward	+125K sh	—	—	125,000
2012-03-14	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, GC & Secretary	AAward	+32.9K sh	—	—	32,857
2012-03-14	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, GC & Secretary	AAward	+155K sh	—	—	155,000
2011-11-21	CADENCE PHARMACEUTICALS INCS Sale	SVP, GC & Secretary	SSale	−10K sh	$4.16	−$41.6K	3,745
2011-11-02	CADENCE PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−10K sh	—	—	0
2011-11-02	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+10K sh	—	—	13,745
2011-03-16	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, GC & Secretary	AAward	+80K sh	—	—	80,000
2010-03-25	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, GC & Secretary	AAward	+15K sh	—	—	215,000
2010-03-25	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, GC & Secretary	AAward	+200K sh	—	—	200,000
2009-08-31	CADENCE PHARMACEUTICALS INCRestricted stock unitsA Award	SVP, GC & Secretary	AAward	+20K sh	—	—	20,000
2009-03-18	CADENCE PHARMACEUTICALS INCstock option (right to buy)A Award	SVP, GC & Secretary	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Jul 314/A
AKER HAZEL M0001209191-20-044356
SEC(opens sec.gov)
Jul 314/A
AKER HAZEL M0001209191-20-044358
SEC(opens sec.gov)
Jul 314/A
AKER HAZEL M0001209191-20-044354
SEC(opens sec.gov)
Jul 314/A
AKER HAZEL M0001209191-20-044359
SEC(opens sec.gov)
Jul 314/A
AKER HAZEL M0001209191-20-044357
SEC(opens sec.gov)
Jul 314/A
AKER HAZEL M0001209191-20-044355
SEC(opens sec.gov)
Jul 234
AKER HAZEL M0001209191-20-043496
SEC(opens sec.gov)
Mar 184
AKER HAZEL M0001209191-20-020087
SEC(opens sec.gov)
Sep 164
AKER HAZEL M0001209191-19-049686
SEC(opens sec.gov)
Jun 114
AKER HAZEL M0000899243-19-016473
SEC(opens sec.gov)
Mar 214
CADENCE PHARMACEUTICALS INC0001209191-14-022389
SEC(opens sec.gov)

Companies

Address

C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200

SAN DIEGO, CA, 92130